Recent Publications Since 2016

  1. Sheng L, Stewart T, Yang D, Thorland E, Soltys D, Aro P, Khrisat T, Xie Z, Li N, Liu Z, Tian C, Bercow M, Matsumoto J, Zabetian CP, Peskind E, Quinn JF, Shi M, Zhang J. (2020) Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis. Acta Neuropathol Commun, 8(1):102. doi: 10.1186/s40478-020-00983-w. PMID: 32641150, PMCID: PMC7346449
  2. Yu Z, Shi M, Stewart T, Fernagut P-O, Huang Y, Tian C, Dehay B, Atik A, Yang D, De Giorgi F, Ichas F, Canron M-H, Ceravolo R, Frosini D, Kim H-J, Feng T, Meissner WG, Zhang J. (2020) Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction. Brain, 143(6):1780-1797. doi: 10.1093/brain/awaa110. PMID: 32428221, PMCID: PMC7296853
  3. Dong Y, Stewart T, Bai L, Li X, Xu T, Iliff J, Shi M, Zheng D, Yuan L, Wei T, Yang X, Zhang J. (2020) Coniferaldehyde attenuates Alzheimer's pathology via activation of Nrf2 and its targets. Theranostics, 10(1): 179-200. doi: 10.7150/thno.36722. eCollection 2020. PMID: 31903114, PMCID: PMC6929631
  4. Tian C, Liu G, Gao L, Soltys D, Pan C, Stewart T, Shi M, Xie Z, Liu N, Feng T, Zhang J. (2019) Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease. Transl Neurodegener, 8: 15. doi: 10.1186/s40035-019-0155-y. eCollection 2019. PMID: 31123587, PMCID: PMC6521422
  5. Stewart T, Shi M, Mehrotra A, Aro P, Soltys D, Kerr KF, Zabetian CP, Peskind ER, Taylor P, Shaw LM, Trojanowski JQ, Zhang J; and from the Alzheimer’s Disease Neuroimaging Initiative. (2019) Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers. J Alzheimers Dis, 69(1): 263-276. doi: 10.3233/JAD-190069. PMID: 30958379, PMCID: PMC6513710
  6. Shi M, Sheng L, Stewart T, Zabetian CP, Zhang J. (2019) New windows into the brain: Central nervous system-derived extracellular vesicles in blood. Prog Neurobiol, 175: 96-106. Review. doi: 10.1016/j.pneurobio.2019.01.005. PMID: 30685501, PMCID: PMC6546433
  7. Cilento EM, Jin L, Stewart T, Shi M, Sheng L, Zhang J. (2019) Mass Spectrometry: A Platform for Biomarker Discovery and Validation for Alzheimer's and Parkinson's Diseases. J Neurochem, 151(4): 397-416. Review. doi: 10.1111/jnc.14635. PMID: 30474862, PMCID: PMC6535381
  8. Wang H, Atik A, Stewart T, Ginghina C, Aro P, Kerr KF, Seibyl J, Jennings D; PARS Investigators, Jensen PH, Marek K, Shi M, Zhang J. (2018) Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study. Neurobiol Dis, 116: 53-59. doi: 10.1016/j.nbd.2018.04.015. PMID: 29705185, PMCID: PMC6294306
  9. Shi M, Tang L, Toledo JB, Ginghina C, Wang H, Aro P, Jensen PH, Weintraub D, Chen-Plotkin AS, Irwin DJ, Grossman M, McCluskey L, Elman LB, Wolk DA, Lee EB, Shaw LM, Trojanowski JQ, Zhang J. (2018) Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease. Alzheimers Dement, 14(8): 1052-1062. doi: 10.1016/j.jalz.2018.02.015. PMID: 29604263, PMCID: PMC6097943
  10. Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A, Aro P, Shaw LM, Trojanowski JQ, Galasko DR, Edland S, Jensen PH, Shi M, Zhang J; Alzheimer’s Disease Neuroimaging Initiative. (2018) A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. J Alzheimers Dis, 61(4): 1541-1553. doi: 10.3233/JAD-171013. PMID: 29376878, PMCID: PMC5828159


Selected Publications Prior to 2016

  • Biomarkers for PD/AD
  • Brain-peripheral blood communication and extracellular vesicles
  • Extracellular α-synuclein and glia in PD
  • Proteomics and its applications in PD/AD


Principle Investigator Bibliographies